Securement of Umbilical Venous Catheter Using Cyanoacrylate Glue: A Randomized Controlled Trial

J Pediatr. 2023 Sep:260:113517. doi: 10.1016/j.jpeds.2023.113517. Epub 2023 May 26.

Abstract

Objective: To evaluate the role of cyanoacrylate glue in reducing dislodgement of umbilical venous catheters (UVCs).

Study design: This was a single-center, randomized, controlled, nonblinded trial. All infants requiring an UVC according to our local policy were included in the study. Infants with a UVC with a centrally located tip as verified by real-time ultrasound examination were eligible for the study. Primary outcome was the safety and efficacy of securement by cyanoacrylate glue plus cord-anchored suture (SG group) vs securement by suture alone (S group), as measured by reduction in dislodgment of the external tract of the catheter. Secondary outcomes were tip migration, catheter-related bloodstream infection, and catheter-related thrombosis.

Results: In the first 48 hours after UVC insertion, dislodgement was significantly higher in the S group than in the SG group (23.1% vs 1.5%; P < .001). The overall dislodgement rate was 24.6% in the S group vs 7.7% in the SG group (P = .016). No differences were found in catheter-related bloodstream infection and catheter-related thrombosis. The incidence of tip migration was similar in both groups (S group 12.2% vs SG group 11.7%).

Conclusions: In our single-center study, cyanoacrylate glue was safe and effective for securement of UVCs, and particularly effective in decreasing early catheter dislodgments.

Trial registration: UMIN-CTR Clinical Trial; Registration number: R000045844.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Catheter-Related Infections*
  • Catheterization, Central Venous*
  • Catheterization, Peripheral*
  • Catheters
  • Cyanoacrylates / therapeutic use
  • Humans
  • Infant
  • Sepsis*
  • Thrombosis*
  • Umbilical Veins
  • Vascular Diseases*
  • Veins

Substances

  • Cyanoacrylates

Associated data

  • JPRN/R000045844